WallStreetZenWallStreetZen

NASDAQ: TVTX
Travere Therapeutics Inc Stock Ownership - Who owns Travere Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Travere Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Elizabeth E. ReedChief Legal Officer and GC2025-05-054,920$21.05
$103.57kSell
Eric M. DubeCHIEF EXECUTIVE OFFICER2025-05-0518,924$21.05
$398.35kSell
Christopher R. ClineCHIEF FINANCIAL OFFICER2025-05-051,784$21.05
$37.55kSell
Peter HeermaCHIEF COMMERCIAL OFFICER2025-05-051,771$21.05
$37.28kSell
William E. RoteChief Research Officer2025-05-053,198$21.05
$67.32kSell
Christopher R. ClineCHIEF FINANCIAL OFFICER2025-04-1148$13.15
$630.96Sell
Jula InrigCHIEF MEDICAL OFFICER2025-02-122,568$23.53
$60.43kSell
Elizabeth E. ReedSVP GC CORPORATE SECRETARY2025-02-128,000$23.53
$188.24kSell
William E. RoteSENIOR VICE PRESIDENT RD2025-02-125,200$23.53
$122.36kSell
Peter HeermaCHIEF COMMERCIAL OFFICER2025-02-122,568$23.53
$60.43kSell

1 of 6

TVTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TVTX insiders and whales buy or sell their stock.

TVTX Shareholders

What type of owners hold Travere Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ruth Shepley55.18%49,000,000$710.50MInsider
Armistice Capital LLC9.99%8,872,000$128.64MInstitution
Blackrock Inc9.22%8,190,544$118.76MInstitution
Janus Henderson Group PLC8.48%7,528,622$109.17MInstitution
Vanguard Group Inc5.65%5,014,020$72.70MInstitution
Macquarie Group Ltd5.40%4,797,314$69.56MInstitution
State Street Corp4.11%3,646,715$52.88MInstitution
Rock Springs Capital Management LP3.29%2,921,196$42.36MInstitution
Driehaus Capital Management LLC3.12%2,767,693$40.13MInstitution
Renaissance Technologies LLC3.04%2,702,814$39.19MInstitution

1 of 3

TVTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TVTX62.84%37.16%Net SellingNet Selling
VRDN74.88%25.12%Net BuyingNet Buying
CVAC3.50%0.00%
GPCR32.40%12.52%
NNNN0.05%0.00%
View Top Biotech Stocks

Travere Therapeutics Stock Ownership FAQ

Who owns Travere Therapeutics?

Travere Therapeutics (NASDAQ: TVTX) is owned by 110.36% institutional shareholders, 65.26% Travere Therapeutics insiders, and 0.00% retail investors. Ruth Shepley is the largest individual Travere Therapeutics shareholder, owning 49.00M shares representing 55.18% of the company. Ruth Shepley's Travere Therapeutics shares are currently valued at $710.50M.

If you're new to stock investing, here's how to buy Travere Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.